Clinical trials for influenza in United States

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults

Study ID: NCT05606965

Sponsor

ModernaTX, Inc.

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

Study ID: NCT04712539

Sponsor

M.D. Anderson Cancer Center

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

Study ID: NCT05787444

Sponsor

LumiraDx UK Limited

Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

Study ID: NCT04794829

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Tell me the truth: verify, debunk, and disseminate

Study ID: NCT06417762

Sponsor

University of Chicago

Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients

Study ID: NCT05663463

Sponsor

University of Minnesota

Revealing Protective Immunity to Influenza Using Systems Immunology

Study ID: NCT06501963

Sponsor

Emory University

Respiratory Virus Sampling and Repository

Study ID: NCT05266222

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Effect of Novel Exhalational Delivery System with Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)

Study ID: NCT05275686

Sponsor

Cedars-Sinai Medical Center

Vaccine Responses in Cancer

Study ID: NCT06605625

Sponsor

Abramson Cancer Center at Penn Medicine